Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Pfizer's total revenue from 2006 to 2018
(in million U.S. dollars)
Pfizer's total revenue 2006-2018
Pfizer is a global pharmaceutical company and among the top pharmaceutical companies in the world. Pfizer is headquartered in New York City. As of 2018, their total revenue was about 53.7 billion U.S. dollars. Since 2006 the company’s revenue has remained relatively stable with some increase in 2010 and 2011. Their lowest revenue year was in 2008 when they generated just 47.5 billion U.S. dollars in revenue.

Pfizer’s global positioning

Pfizer’s products are available in over 125 countries worldwide and as of 2018 they have over 100 clinical research and development projects underway. Pfizer is the top pharmaceutical company based on global prescription drug sales and is among the top 5 pharmaceutical companies based on research and development (R&D) spending. Pfizer’s largest segment is Innovative Health (IH). The Innovative Health business focuses on various rare diseases, vaccines, immunology and internal medicine to name a few.

Pfizer’s top products

Pfizer has several products that are quite popular. In 2018, drugs in the Prevnar family, followed by Lyrica, were their top products based on revenue. However, Pfizer has several other drugs that are also well known. For example, Lipitor (atorvastatin calcium) is used in the treatment of high cholesterol. Over the years, however, Lipitor revenues have been on the decline, yet it remains part of Pfizer’s top products. One of Pfizer’s most well-known products, Viagra (sildenafil citrate), used in the treatment of erectile disfunction, has also been on the decline with 2018 having the lowest revenues on record. The low revenues are mainly attributable to Viagra’s loss of patent exclusivity in the U.S. in December 2017.
Pfizer's total revenue from 2006 to 2018
(in million U.S. dollars)
Revenue in millions of U.S. dollars
--
--
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Pfizer's total revenue 2006-2018
Pfizer is a global pharmaceutical company and among the top pharmaceutical companies in the world. Pfizer is headquartered in New York City. As of 2018, their total revenue was about 53.7 billion U.S. dollars. Since 2006 the company’s revenue has remained relatively stable with some increase in 2010 and 2011. Their lowest revenue year was in 2008 when they generated just 47.5 billion U.S. dollars in revenue.

Pfizer’s global positioning

Pfizer’s products are available in over 125 countries worldwide and as of 2018 they have over 100 clinical research and development projects underway. Pfizer is the top pharmaceutical company based on global prescription drug sales and is among the top 5 pharmaceutical companies based on research and development (R&D) spending. Pfizer’s largest segment is Innovative Health (IH). The Innovative Health business focuses on various rare diseases, vaccines, immunology and internal medicine to name a few.

Pfizer’s top products

Pfizer has several products that are quite popular. In 2018, drugs in the Prevnar family, followed by Lyrica, were their top products based on revenue. However, Pfizer has several other drugs that are also well known. For example, Lipitor (atorvastatin calcium) is used in the treatment of high cholesterol. Over the years, however, Lipitor revenues have been on the decline, yet it remains part of Pfizer’s top products. One of Pfizer’s most well-known products, Viagra (sildenafil citrate), used in the treatment of erectile disfunction, has also been on the decline with 2018 having the lowest revenues on record. The low revenues are mainly attributable to Viagra’s loss of patent exclusivity in the U.S. in December 2017.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Pfizer
Pfizer

All Information
in one Presentation

Pfizer

Everything On "Pfizer" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pfizer"
  • Global positioning
  • Revenues
  • Selected top products
  • Expenditures/payments
  • Other key data
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.